Anti-TNFR2 antibody and use thereof
US12297284B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 31, 2020 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Mar 20, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7151
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is an antibody or an antigen-binding fragment thereof capable of specifically binding to TNFR2, wherein the antibody or the antigen-binding fragment thereof is capable of regulating the function of immune cells and may be used as a medicament to treat diseases related to immune-related disorders, such as tumors. A polynucleotide encoding the antibody or antigen-binding fragment thereof and a pharmaceutical composition comprising the antibody or antigen binding fragment thereof are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.